Sialadenitis May Be Associated With an Increased Risk for Osteoradionecrosis: A Nationwide Population-Based Cohort Study.


Journal

Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
ISSN: 1531-5053
Titre abrégé: J Oral Maxillofac Surg
Pays: United States
ID NLM: 8206428

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 08 08 2018
revised: 28 01 2019
accepted: 28 01 2019
pubmed: 4 3 2019
medline: 8 8 2020
entrez: 4 3 2019
Statut: ppublish

Résumé

The impact of sialadenitis on osteoradionecrosis (ORN) is controversial. The aim of this study was to determine the association between sialadenitis and ORN. Participants were derived from the Taiwanese Longitudinal Health Insurance Database. From January 1, 2000 to December 31, 2008, cases of sialadenitis (International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM] codes 527.2, 527.3, 527.5 to 527.7, 527.9, and 710.2) and ORN (ICD-9-CM codes 526.89, 526.5, 730.0, and 730.1) were identified. Different treatment modalities, including surgery versus medicine, were used to distinguish the severity of sialadenitis. The primary predictor variable was sialadenitis. The secondary predictor variable was severity of sialadenitis. The primary outcome variable was time to developing ORN. Other study variables were grouped for age, gender, risk factor, and medical treatment. Cox proportional hazard regression was used to investigate the associations between sialadenitis and ORN after adjusting for statistical confounders. The sample was composed of 47,385 patients with a mean age of 46.6 years (standard deviation, 19.9 yr) and 37.2% were men. Twenty percent had a diagnosis of sialadenitis and 1.13% had a diagnosis of ORN. Sialadenitis was associated with an increased risk of ORN (hazard ratio [HR] = 1.93; 95% confidence interval [CI], 1.61-2.31; P < .0001). After adjustment for confounders, sialadenitis was associated with ORN (multivariable HR = 1.83; 95% CI, 1.52-2.19; P < .0001). Severity of sialadenitis was associated with an increased risk of ORN; risks for ORN were 1.79 (95% CI, 1.49-2.16; P < .0001) and 3.52 (95% CI, 1.67-7.44; P < .001) in patients with mild and serious sialadenitis, respectively, compared with the no-sialadenitis cohort. For the joint effect of ORN between sialadenitis and malignancy type, patients with sialadenitis had 11.6-fold risk for ORN (95% CI, 5.58-23.9) compared with patients without malignancy. Sialadenitis markedly increased the risk to develop ORN. The severity of sialadenitis was positively correlated with the incidence of ORN.

Identifiants

pubmed: 30826391
pii: S0278-2391(19)30122-3
doi: 10.1016/j.joms.2019.01.047
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1392-1400

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2019 American Association of Oral and Maxillofacial Surgeons. All rights reserved.

Auteurs

Yi-Fang Huang (YF)

Assistant Professor, Department of General Dentistry, Chang Gung Memorial Hospital, Linkou; Adjunct Lecturer, School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan.

Shih-Ping Liu (SP)

Associate Professor, Graduate Institute of Basic Medical Science, China Medical University, Taichung; Associate Professor, Center for Neuropsychiatry, China Medical University Hospital, Taichung; Associate Professor, Department of Social Work, Asia University, Taichung, Taiwan.

Chih-Hsin Muo (CH)

Researcher, Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan.

Chung-Ta Chang (CT)

Adjunct Assistant Professor, School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei; Associate Professor, Department of Emergency Medicine, Far Eastern Memorial Hospital, New Taipei, Taiwan. Electronic address: chungta2001@gmail.com.

Chun-Hao Tsai (CH)

Associate Professor, Department of Orthopedics, China Medical University Hospital, Taichung; Associate Professor, Graduate Institute of Clinical Medicine, China Medical University, Taichung, Taiwan.

Donald E Morisky (DE)

Professor, Department of Community Health Sciences, UCLA Fielding School of Public Health, Los Angeles, CA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH